Details
Stereochemistry | ACHIRAL |
Molecular Formula | C15H23NS.ClH |
Molecular Weight | 285.876 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
Cl.C1CCN(CC1)C2(CCCCC2)C3=CC=CS3
InChI
InChIKey=IIPLEZRBGQCZMF-UHFFFAOYSA-N
InChI=1S/C15H23NS.ClH/c1-3-9-15(10-4-1,14-8-7-13-17-14)16-11-5-2-6-12-16;/h7-8,13H,1-6,9-12H2;1H
Molecular Formula | C15H23NS |
Molecular Weight | 249.415 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
Molecular Formula | ClH |
Molecular Weight | 36.461 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
Tenocyclidine (TCP) is a dissociative anesthetic drug with psychostimulant and hallucinogenic effects. This drug shows a broad spectrum of pharmacological activity including antidotal effect in organophosphorus compounds poisoning, radioprotective and anticancer effects. It was studied that the antidotal potency could protect acetylcholinesterase (AChE) in the case of organophosphate poisoning. However, the controversial role of TCP in brain protection should be studied further. Tenocyclidine has a high affinity for the N-methyl-D-aspartate (NMDA) receptors. This property allows using of TCP binding (association rate) as a marker of channel opening and thereby permitting measurement of NMDA receptor activation and ligand binding under identical conditions.
Approval Year
PubMed
Title | Date | PubMed |
---|---|---|
Decreased density of [3H]TCP binding following antipsychotic drug withdrawal in rats. | 2002 Apr 19 |
|
Characterization of the non-competitive antagonist binding site of the NMDA receptor in dark Agouti rats. | 2004 Aug 6 |
|
[An expert study of acute poisoning by phencyclidine derivatives]. | 2004 May-Jun |
|
Molecular mechanisms and binding site location for the noncompetitive antagonist crystal violet on nicotinic acetylcholine receptors. | 2006 Feb 21 |
|
The role of antagonism of NMDA receptor-mediated neurotransmission and inhibition of the dopamine reuptake in the neuroendocrine effects of phencyclidine. | 2006 Mar 20 |
|
Influences of different developmental periods of taurine supplements on synaptic plasticity in hippocampal CA1 area of rats following prenatal and perinatal lead exposure. | 2007 May 19 |
|
Molecular properties of local anesthetics as predictors of affinity for nicotinic acetylcholine receptors. | 2007 Oct |
|
Tenocyclidine treatment in soman-poisoned rats--intriguing results on genotoxicity versus protection. | 2008 |
|
Engineering and characterization of a mouse/human chimeric anti-phencyclidine monoclonal antibody. | 2008 Jan |
|
High specific activity tritiation of TCP and BTCP. | 2009 Jun |
|
Inhibition of the histone demethylase LSD1 blocks alpha-herpesvirus lytic replication and reactivation from latency. | 2009 Nov |
|
1,2-ethane bis-1-amino-4-benzamidine is active against several brain insult and seizure challenges through anti-NMDA mechanisms targeting the 3H-TCP binding site and antioxidant action. | 2010 Jul |
|
Qualitative GC-MS assessment of TCP and TAMORF elimination in rats. | 2010 Mar |
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 16:25:53 GMT 2023
by
admin
on
Fri Dec 15 16:25:53 GMT 2023
|
Record UNII |
425WW340S2
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Code | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Code | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
40903
Created by
admin on Fri Dec 15 16:25:53 GMT 2023 , Edited by admin on Fri Dec 15 16:25:53 GMT 2023
|
PRIMARY | |||
|
425WW340S2
Created by
admin on Fri Dec 15 16:25:53 GMT 2023 , Edited by admin on Fri Dec 15 16:25:53 GMT 2023
|
PRIMARY | |||
|
DBSALT002317
Created by
admin on Fri Dec 15 16:25:53 GMT 2023 , Edited by admin on Fri Dec 15 16:25:53 GMT 2023
|
PRIMARY | |||
|
16640802
Created by
admin on Fri Dec 15 16:25:53 GMT 2023 , Edited by admin on Fri Dec 15 16:25:53 GMT 2023
|
PRIMARY | |||
|
1867-65-8
Created by
admin on Fri Dec 15 16:25:53 GMT 2023 , Edited by admin on Fri Dec 15 16:25:53 GMT 2023
|
PRIMARY | |||
|
DTXSID40904770
Created by
admin on Fri Dec 15 16:25:53 GMT 2023 , Edited by admin on Fri Dec 15 16:25:53 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
PARENT -> SALT/SOLVATE |
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |